All In MedTech

Device Trial Radar · NCT00462124

Evaluation of the Safety and Efficacy of the BioProtect Balloon in Prostate Cancer Subjects Undergoing Radiotherapy

One-arm, Multi-center, Prospective Study to Assess the Safety and Efficacy of BioProtect Biodegradable Implantable Balloon in Prostate Cancer Subjects Undergoing Radiotherapy

Last checked: Nov 20, 2026Latest source record: Aug 8, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

7

Actual

Start

Jun 2007

Primary completion

Mar 2009

Study completion May 2009

Sponsor

Lead sponsor
BioProtectNot on our public-company list
Sponsor type
Industry
First posted
Apr 18, 2007

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Prevention
Who can join
Male only, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Primary Goal The study's primary goal is to assess the safety of the BioProtect biodegradable balloon implant and implantation procedure, in prostate cancer subjects undergoing routine XRT treatment. Safety of the BioProtect device will be assessed by reporting adverse events. Secondary Goal The study's secondary goal is to evaluate the effectiveness of the BioProtect biodegradable balloon implant in prostate cancer subjects undergoing routine XRT treatment. Effectiveness will be assessed in terms of increased distance between anterior rectal wall and prostate and noticeable reduction of isodose to the rectum.

Conditions

  • Prostate Cancer

Interventions

  • Absorbable perirectal spacerDevice

    biodegradable balloon implant to increase the distance between prostate and anterior rectal wall

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety of Balloon ImplantTime frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Ichilov Medical Center

    Tel Aviv, Israel

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.